Discontinued — last reported Q3 '20

Other

Debt Instrument, Fair Value Disclosure

Thermo Fisher Scientific Debt Instrument, Fair Value Disclosure increased by 8.6% to $39.75B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ3 2020

How to read this metric

A fair value significantly lower than the carrying amount may indicate favorable market conditions for debt buybacks.

Detailed definition

This represents the estimated fair market value of the firm's long-term debt instruments, which may differ from the carr...

Peer comparison

Required disclosure for public companies to show the market-based valuation of debt.

Metric ID: other_debt_instrument_fair_value

Historical Data

2 periods
 Q4 '25Q1 '26
Value$36.61B$39.75B
QoQ Change—+8.6%
Range$36.61B – $39.75B

Debt Instrument, Fair Value Disclosure at Other Companies

IR
Ingersoll RandIRView metric

Frequently Asked Questions

What is Thermo Fisher Scientific's debt instrument, fair value disclosure?
Thermo Fisher Scientific (TMO) reported debt instrument, fair value disclosure of $39.75B in Q1 2026.
What does debt instrument, fair value disclosure mean?
The current market value of the company's long-term debt.